| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $425K | — | +24.5% |
| Cost of Revenue | $159K | — | +35.3% |
| R&D Expense | $1.3M | — | -55.9% |
| SG&A Expense | $1.8M | — | +3.5% |
| Operating Income | -$4.2M | — | +22.7% |
| Pre-tax Income | $846K | — | +114.3% |
| Income Tax | $0 | — | +100.0% |
| Net Income | $846K | — | +114.3% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.4M | -41.9% | +41.0% |
| Accounts Receivable | $172K | -72.1% | -26.3% |
| Inventory | $6.1M | +6.4% | +58.1% |
| Current Assets | $12.3M | -25.0% | +35.2% |
| Total Assets | $16.5M | -20.4% | +24.2% |
| Current Liabilities | $3.2M | -13.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | +13.0% |
| Capital Expenditures | $79K | — | -18.1% |
| Investing Cash Flow | -$79K | — | +18.1% |
| Financing Cash Flow | $342K | — | -93.5% |
| Free Cash Flow | -$4.2M | — | +13.1% |
| -67.9% |
| Total Liabilities | $9.2M | -38.0% | -18.4% |
| Stockholders' Equity | $7.3M | +24.2% | +265.1% |